Articles tagged with Blood Glucose
Researchers discovered that a specific group of glucose-sensing neurons in the brain, known as GI neurons, play a crucial role in maintaining blood glucose balance. These neurons are activated when glucose levels are low and inhibited when levels are high, helping to regulate whole-body glucose levels.
A case series study demonstrated that a whole-food, plant-predominant dietary pattern and standard medical treatment can successfully achieve type 2 diabetes remission in 37 percent of patients. The study contributes novel information on the feasibility of achieving remission simply by eating healthy food.
Children and teenagers with diabetes frequently employ inaccurate CGM alarm settings, which may lead to reduced usefulness of these devices. Research highlights the importance of following recommended alarm best practices to ensure patients receive real-time glycemic data while minimizing alarm fatigue.
Researchers at UBC Okanagan found that a low-carb breakfast can significantly reduce blood sugar swings and improve glucose control. Participants who followed a low-carb breakfast plan showed lower glycemic variability and some were able to reduce their glucose-lowering medication.
Researchers developed a biofuel cell on a chip that measures blood glucose levels using a few microliters of blood. The sensor generates an electrical signal based on the enzyme's reaction with glucose, providing accurate readings using general-purpose devices like smartphones.
A new method of analysis flags impaired glucose homeostasis (IGH) in 20% of 'healthy' participants using continuous glucose monitors. This finding has significant implications for early detection and prevention of Type 2 diabetes, with the potential to impact millions worldwide.
A study published in JAMA Network Open found that higher cumulative blood sugar levels after a stroke contribute to faster cognitive decline. Researchers adjusted data for various factors and discovered no association between high blood pressure or cholesterol and accelerated cognitive loss.
A new study published in JMIR Diabetes found that Fitterfly's diabetes digital therapeutics program improved glycemic control and weight management in participants with type 2 diabetes. The 90-day program led to significant reductions in hemoglobin A1c levels and body weight.
A recent study published in PLOS ONE found that patients with Type 2 diabetes who have full chewing function have significantly lower blood glucose levels compared to those with impaired chewing ability. The research highlights the importance of dental care and occlusal function in managing blood sugar levels.
Updated guidelines recommend discontinuing antibiotics immediately after a patient's incision is closed. Continuing antibiotics increases risk of C. difficile infection and antimicrobial resistance, but does not prevent surgical site infections.
Rice University scientists developed a screening technique to identify high-performing biomaterials for encapsulating insulin-secreting cells, providing long-term blood sugar level control in diabetic mice. The study's findings have the potential to open the door to a more sustainable and self-regulating way to treat Type 1 diabetes.
A recent analysis of three clinical trials found that the UVA-developed artificial pancreas improved blood sugar control by 13 percentage points and decreased hemoglobin A1c levels. The device spent an average of 2.8 more hours per day in target blood sugar range, benefiting both kids and adults with diabetes.
Researchers found that women with prediabetes after pregnancy had aberrations in their early pregnancy blood serum metabolomic profile, including higher concentrations of small HDL particles. These metabolic changes predicted prediabetes at postpartum and were associated with increased risk of type 2 diabetes.
Researchers at the University of Washington developed GlucoScreen, a new system that leverages smartphone capacitive touch sensing to measure blood glucose levels. The system's accuracy is comparable to standard glucometer testing, making it potentially less costly and more accessible for widespread screening.
A new class of compounds reduces weight dramatically and lowers blood glucose in lab animals, boosting calorie burn and avoiding nausea. The injectable treatments activate multiple gut hormone receptors, including GLP-1 and PYY, to signal fullness and curb appetite.
A team of researchers at ETH Zurich has created an implantable fuel cell that uses excess blood sugar to generate electrical energy. The device powers artificial beta cells that produce insulin, effectively regulating blood glucose levels.
A clinical study found that children ages 2 to 6 with type 1 diabetes using an artificial pancreas system spent more time in their target blood sugar range, reducing anxiety for families. The system improved nighttime blood glucose control and was used safely by participants.
UVA researchers discovered a metabolic pathway that can modulate COVID-19 inflammation, lung recovery, and host metabolic health. They suggest a potentially viable therapeutic agent that may be combined with existing anti-viral agents to treat severe COVID-19 in patients with underlying metabolic disease.
A new study published in Journal of Diabetes Investigation found a significant link between self-stigma and suboptimal glycated hemoglobin (HbA1c) levels in adults with type 1 diabetes. The research highlights the importance of eliminating self-stigma in managing the condition.
A new study uses machine learning to predict poor glycemic control in patients with type 2 diabetes, identifying key factors such as prior glucose levels and anti-diabetic medicines. The findings suggest that data routinely collected for diabetes monitoring can reliably identify patients at risk of hyperglycemia.
Researchers have developed an orally administered tablet powered by chemical micromotors that deliver insulin to the colon, reducing blood glucose levels for over five hours. The mini-tablets protected from stomach acid and used hydrogen gas bubbles as micromotors to propel insulin into the bloodstream.
Researchers at UNIST developed a subcutaneously implantable electromagnetic biosensor system for continuous glucose monitoring. The new technology eliminates the need for frequent finger pricking, providing more accurate blood glucose level tracking and improved patient care.
Researchers found that individuals with CYP8B1 loss-of-function mutations have improved insulin sensitivity and better glucose regulation, reducing the risk of developing Type 2 diabetes. The study suggests a potential new treatment approach using bile acid modulators to target this gene.
Researchers found that raw honey from single floral sources lowers fasting blood glucose, total and LDL cholesterol, triglycerides, and inflammation. Honey's health benefits depend on processing, floral source, and quantity.
A new study found that afternoon or evening physical activity is associated with reduced liver fat content and improved insulin sensitivity. Performing MVPA in the afternoon or evening was linked to reduced insulin resistance by 18% and 25% respectively.
A team of researchers at USC is launching a comprehensive study to investigate the connection between type 2 diabetes and dementia in adults with Hispanic ancestry. The five-year study will examine brain structure and activity, blood flow, blood glucose and insulin levels, and cognitive functioning in 200 participants.
Helmholtz Munich researchers identified a novel strategy to alter glucagon receptor signaling by changing its intracellular localization. This approach offers therapeutic potential for treating type 2 diabetes by uncoupling glucose and lipid metabolism-related effects.
A large clinical trial found that insulin glargine and liraglutide were superior to other diabetes drugs in controlling blood sugars. The study, published in the New England Journal of Medicine, compared four common medications used to treat type 2 diabetes when added to metformin.
A new clinical trial found that the bionic pancreas device was more effective at maintaining blood glucose levels within normal range than standard-of-care management among people with type 1 diabetes. The device requires minimal user input and provides more automation, resulting in improved glycemic control.
A new non-invasive blood glucose monitoring process was developed by researchers at Kennesaw State University, which can accurately measure blood glucose levels without taking a sample. The GlucoCheck process uses light and camera technology to capture images of the skin and determine blood glucose concentration with 90% accuracy.
A bionic pancreas, which automatically delivers insulin based on blood glucose levels, was more effective than standard care at maintaining normal blood sugar levels. The study, funded by NIDDK and conducted at Nemours Children's Health, Jacksonville, found the device to require less user input and provide more automation.
Researchers found that all mind-body practices led to significant reductions in blood sugar levels, with yoga providing the largest benefit. The study suggests that these practices could be used as a complementary nonpharmacological treatment or preventive measure for type 2 diabetes.
Researchers found that knocking out TXNIP in alpha cells improves diabetes-associated hyperglycemia and hyperglucagonemia. This discovery suggests a new potential treatment for Type 1 diabetes.
Researchers at the University of Houston have discovered a way to activate the soleus muscle, which can sustain elevated oxidative metabolism and improve blood glucose regulation for hours. The 'soleus pushup' movement has been shown to increase oxygen consumption and reduce insulin requirements.
Research at Karolinska Institutet shows that people with diabetes have lower levels of psoriasin, a key peptide that weakens the bladder's protective barrier function. This increases the risk of urinary tract infections. Oestrogen therapy may help regulate the immune response to UTIs in patients with diabetes.
Researchers at Nagoya University have discovered a new treatment for type 1 diabetes that uses leptin to improve insulin-alternative effects in mice. The combination of leptin and a PTP1B inhibitor normalizes blood glucose levels without the need for insulin, reducing hypoglycemia risk.
A study published in Nature Communications suggests that better glucose control can improve brain structure and function in youth with Type 1 diabetes. The findings indicate that participants using a hybrid closed-loop insulin delivery system showed significant improvement in key brain metrics compared to those receiving standard care.
A new study from Edith Cowan University found that acupuncture therapy significantly improved fasting plasma glucose, two-hour plasma glucose, and glycated haemoglobin levels in people with prediabetes. The therapy also showed a greater decline in the incidence of prediabetes without adverse reactions.
A recent study published in Nutrients suggests that regular quinoa consumption can help prevent type 2 diabetes. Researchers replaced carbohydrate-rich foods with quinoa and found a significant reduction in post-meal blood sugar spikes. By mitigating this spike, quinoa may play a crucial role in preventing the progression of type 2 dia...
A new study found that consuming green tea extract for four weeks can lower blood sugar levels, improve gut health, and decrease inflammation in healthy individuals and those with metabolic syndrome. Researchers observed a significant reduction in fasting blood glucose levels and decreased gut permeability.
A new study by the University of Pittsburgh found that patients with diabetes on Medicare Advantage plans are more likely to receive preventive treatments, but less likely to receive newer and more expensive medications. This disparity can lead to poorer health outcomes, including higher blood pressure and worse diabetes control.
A recent study published in Circulation Journal Report reveals that only 20% of U.S. adults and children have ideal cardiovascular health. The Life's Essential 8 checklist, updated by the American Heart Association, assesses heart health through eight key components, including diet, physical activity, and sleep duration.
Researchers found that factory-calibrated continuous glucose monitors are sufficiently accurate for estimating blood-sugar levels in patients with end-stage renal disease on hemodialysis. The devices showed 'clinical reliability', with almost 99% of readings accurate enough to be used without confirmatory fingerstick blood sugar readings.
Researchers at Beth Israel Deaconess Medical Center have identified a key enzyme involved in producing a new class of lipids with therapeutic effects for patients with diabetes. The discovery, published in Nature, could pave the way for new treatments to protect insulin-producing cells and improve blood sugar control.
Researchers at Karolinska Institutet describe a new way of generating insulin-producing cells using a molecule that stimulates protein synthesis and boosts insulin production. The study shows promise for treating type 1 and 2 diabetes, potentially increasing the number of insulin-producing pancreatic β cells.
A customized WeightWatchers program has been shown to effectively manage Type 2 diabetes by lowering blood glucose levels and promoting significant weight loss. Participants in the six-month clinical trial experienced improved glycemic control and overall well-being, with clinically meaningful and statistically significant results.
Research describes how breast cancer cells impair pancreatic islet function to suppress insulin production, leading to diabetes and increased tumor growth. The study identifies microRNA-122 as a key player in this process.
A recent study published in the Journal of Endocrinology suggests that lowering blood glucose levels can partially restore reproductive hormone levels and ovulation in female mice with obesity. The study used dapagliflozin, a common type 2 diabetes medication, to treat the mice, resulting in improved fertility outcomes.
A recent study found that obesity, impaired blood glucose metabolism, and high blood pressure significantly increase the risk of dying from COVID-19 in young and middle-aged people. Researchers analyzed data from the European case registry LEOSS and found that patients with all three conditions had a similar increased risk of death as ...
A new study suggests that glucose-lowering medications can restore aerobic exercise capacity in people with high blood sugar. The research, published in the journal Diabetes, found that combining a medication like canagliflozin with exercise training may improve exercise response in individuals with diabetes.
Research suggests that ecotourists' sugar-fed wildlife interactions are causing northern Bahamian rock iguanas to develop high blood sugar levels. The study found that iguanas on islands frequently visited by tourists had higher glucose peaks and difficulty regulating their blood sugar.
A GE Research-led team has demonstrated the ability to prevent or reverse diabetes in preclinical model systems using ultrasound-based bioelectronic medicine. The team's findings, published in Nature Biomedical Engineering, represent a significant milestone in this field and pave the way for future clinical translation.
Researchers at Karolinska Institutet have identified a new antidiabetic substance that preserves beta cell activity and prevents high blood glucose in mice. This approach may prevent the exhaustion of beta cells and improve long-term diabetes treatment.
A new study suggests that people with type 1 diabetes who have high levels of psychological resilience are more likely to manage their condition successfully. The research found that those with low resilience also had poorer blood sugar control after two years.
Research suggests exercise can break the vicious cycle of inflammation that leads to diabetes and depression in people with Long COVID. A 30-minute session of moderate-intensity exercise, such as walking, can be beneficial.
A panel study in Beijing found a consistent, robust increase in fasting blood glucose levels after exposure to ultrafine particles (UFPs). The research suggests potential biological pathways, including pro-opiomelanocortin processing and regulation of hypoxia-inducible factor 1 A function.
Researchers at MIT have developed an all-in-one approach to diabetes treatment, streamlining the process of blood glucose measurement and insulin injection. The new device can automate procedures such as pricking skin, collecting blood, calculating glucose levels, and dispensing insulin, reducing the need for multiple devices and makin...
A new study from Brigham and Women's Hospital identified the activation of PIEZO1 as a key trigger for thrombosis in patients with type 2 diabetes. Inhibiting PIEZO1 prevented clot formation, suggesting its potential as a therapeutic target for preventing thrombosis.
Researchers at Salk Institute have discovered a new molecular pathway that controls blood glucose levels independent of insulin, offering new avenues for treating diabetes and metabolic disorders. The hormone FGF1 suppresses lipolysis and regulates glucose production in the liver.
A small study published in the Journal of Clinical Endocrinology & Metabolism found that exercising at high altitude can lead to lower blood sugar levels in individuals with type 1 diabetes. This may increase the risk of hypoglycemia, which can be life-threatening if not treated promptly.